Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Influence of low-density lipoprotein (LDL) receptor on lipid composition, inflammation and parasitism during Toxoplasma gondii infection.

Portugal LR, Fernandes LR, Pietra Pedroso VS, Santiago HC, Gazzinelli RT, Alvarez-Leite JI.

Microbes Infect. 2008 Mar;10(3):276-84. doi: 10.1016/j.micinf.2007.12.001. Epub 2007 Dec 8.

PMID:
18316222
2.

Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57Bl/6 mice.

Herijgers N, Van Eck M, Groot PH, Hoogerbrugge PM, Van Berkel TJ.

Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1961-7.

PMID:
10938018
3.

Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.

Hasan ST, Zingg JM, Kwan P, Noble T, Smith D, Meydani M.

Atherosclerosis. 2014 Jan;232(1):40-51. doi: 10.1016/j.atherosclerosis.2013.10.016. Epub 2013 Oct 31.

PMID:
24401215
4.

FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice.

Zhang Y, Wang X, Vales C, Lee FY, Lee H, Lusis AJ, Edwards PA.

Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2316-21. Epub 2006 Jul 6.

PMID:
16825595
5.

Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A.

Babaev VR, Gleaves LA, Carter KJ, Suzuki H, Kodama T, Fazio S, Linton MF.

Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2593-9.

PMID:
11116058
6.

Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice.

Babaev VR, Patel MB, Semenkovich CF, Fazio S, Linton MF.

J Biol Chem. 2000 Aug 25;275(34):26293-9.

7.

Host cholesterol and inflammation as common key regulators of toxoplasmosis and artherosclerosis development.

Portugal LR, Fernandes LR, Alvarez-Leite JI.

Expert Rev Anti Infect Ther. 2009 Sep;7(7):807-19. doi: 10.1586/eri.09.60. Review.

PMID:
19735223
8.

Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice.

Kennedy DJ, Kuchibhotla SD, Guy E, Park YM, Nimako G, Vanegas D, Morton RE, Febbraio M.

Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1481-7. doi: 10.1161/ATVBAHA.109.191940. Epub 2009 Jul 16.

9.

A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation.

Linton MF, Babaev VR, Gleaves LA, Fazio S.

J Biol Chem. 1999 Jul 2;274(27):19204-10.

10.

Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.

Babaev VR, Ishiguro H, Ding L, Yancey PG, Dove DE, Kovacs WJ, Semenkovich CF, Fazio S, Linton MF.

Circulation. 2007 Sep 18;116(12):1404-12. Epub 2007 Aug 27.

PMID:
17724261
11.

Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice.

Semenkovich CF, Coleman T, Daugherty A.

J Lipid Res. 1998 Jun;39(6):1141-51.

12.

Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice.

Herijgers N, Van Eck M, Groot PH, Hoogerbrugge PM, Van Berkel TJ.

Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):1995-2003.

PMID:
9351364
13.

Host cholesterol synthesis contributes to growth of intracellular Toxoplasma gondii in macrophages.

Nishikawa Y, Ibrahim HM, Kameyama K, Shiga I, Hiasa J, Xuan X.

J Vet Med Sci. 2011 May;73(5):633-9. Epub 2010 Dec 24.

14.

Effect of aging on aortic expression of the vascular cell adhesion molecule-1 and atherosclerosis in murine models of atherosclerosis.

Merat S, Fruebis J, Sutphin M, Silvestre M, Reaven PD.

J Gerontol A Biol Sci Med Sci. 2000 Feb;55(2):B85-94.

PMID:
10737683
15.

Infection with Toxoplasma gondii increases atherosclerotic lesion in ApoE-deficient mice.

Portugal LR, Fernandes LR, Cesar GC, Santiago HC, Oliveira DR, Silva NM, Silva AA, Lannes-Vieira J, Arantes RM, Gazzinelli RT, Alvarez-Leite JI.

Infect Immun. 2004 Jun;72(6):3571-6.

16.

Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).

Sanan DA, Newland DL, Tao R, Marcovina S, Wang J, Mooser V, Hammer RE, Hobbs HH.

Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4544-9.

17.

Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.

Romeo GR, Moulton KS, Kazlauskas A.

Circ Res. 2007 Aug 17;101(4):357-67. Epub 2007 Jul 5.

PMID:
17615372
18.

LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.

Brousseau ME, Kauffman RD, Herderick EE, Demosky SJ Jr, Evans W, Marcovina S, Santamarina-Fojo S, Brewer HB Jr, Hoeg JM.

Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):450-8.

PMID:
10669643
19.

Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.

Sberna AL, Assem M, Xiao R, Ayers S, Gautier T, Guiu B, Deckert V, Chevriaux A, Grober J, Le Guern N, Pais de Barros JP, Moore DD, Lagrost L, Masson D.

Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2232-9. doi: 10.1161/ATVBAHA.110.222497. Epub 2011 Jul 21.

20.

Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR(-/-) and ApoE(-/-) mice.

Ryu SK, King TJ, Fujioka K, Pattison J, Pashkow FJ, Tsimikas S.

Atherosclerosis. 2012 May;222(1):99-105. doi: 10.1016/j.atherosclerosis.2012.02.002. Epub 2012 Feb 8.

PMID:
22406426

Supplemental Content

Support Center